Myomo (MYO) Cash from Operations (2016 - 2025)
Myomo (MYO) posted Cash from Operations of 1828780.0 for Q3 2025, up 79.37% on a QoQ basis from 8865276.0 in Q2 2025, and down 22.4% year-over-year from 2356569.05 in Q3 2024.
Myomo (MYO) Cash from Operations (2016 - 2025) Analysis & Trends
Myomo's Cash from Operations history runs 10 years deep, the most recent figure standing at 1828780.0 for Q3 2025.
- Quarterly Cash from Operations fell 22.4% year-over-year to 1828780.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 10005227.0 (down 11.03% YoY) and the FY2024 annual result came in at 3289904.0, up 46.7% from the prior year.
- Cash from Operations was 1828780.0 for Q3 2025 at Myomo, up from 8865276.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 3365728.0 in Q4 2024 and bottomed at 8865276.0 in Q2 2025.
- A 5-year average of 2242887.37 and a median of 2190486.0 in 2021 frame the typical range for Cash from Operations.
- Peak annual rise in Cash from Operations reached 242.87% in 2024, while the deepest fall reached 571.02% in 2024.
- Myomo's Cash from Operations stood at 1847695.0 in 2021, then plunged by 33.37% to 2464221.0 in 2022, then advanced by 4.4% to 2355744.0 in 2023, then surged by 242.87% to 3365728.0 in 2024, then plunged by 154.34% to 1828780.0 in 2025.
- Business Quant data shows MYO's Cash from Operations at 1828780.0 in Q3 2025, 8865276.0 in Q2 2025, and 2676899.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.83 Mn |
| Sep 30, 2025 | -1.83 Mn |
| Jun 30, 2025 | -8.87 Mn |
| Jun 30, 2025 | -8.87 Mn |
| Mar 31, 2025 | -2.68 Mn |
| Mar 31, 2025 | -2.68 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Sep 30, 2024 | -1.49 Mn |
| Sep 30, 2024 | -1.49 Mn |
| Jun 30, 2024 | -1.92 Mn |
| Jun 30, 2024 | -1.92 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Dec 31, 2023 | -2.36 Mn |
| Dec 31, 2023 | -2.36 Mn |
| Sep 30, 2023 | -1.71 Mn |
| Sep 30, 2023 | -1.71 Mn |
| Jun 30, 2023 | -285,523.00 |
| Jun 30, 2023 | -285,523.00 |